title: Alternate treatments in asthma.
authors.affiliation: Pulmonary/Critical Care Medicine Service, William Beaumont Army Medical Center, El Paso, TX 79920, USA. Alexander.Niven@amedd.army.mil
authors.forename: Alexander S
authors.initials: AS
authors.lastname: Niven
authors.forename: Gregory
authors.initials: G
authors.lastname: Argyros
mesh_terms: D018927:Anti-Asthmatic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005665:Furosemide / Q000494:pharmacology / Q000627:therapeutic use; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects; D014217:Troleandomycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D018927:Anti-Asthmatic Agents; D000925:Anticoagulants; D004232:Diuretics; D005493:Folic Acid Antagonists; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D006046:Gold; D005665:Furosemide; D016572:Cyclosporine; D006493:Heparin; D014217:Troleandomycin; D008727:Methotrexate